Based on current clinical evidence, tirzepatide (Zepbound) produces the highest average weight loss, followed by semaglutide (Wegovy), and then liraglutide (Saxenda)
BPC-157 is most commonly administered via a small subcutaneous injection, which is quick, virtually painless, and easy to manage at home
Semaglutide alone can cause side effects like nausea, vomiting, diarrhea, and, in some cases, digestive discomfort
Prime/MRxs suite of offerings including intervention programs, such as HighTouch Rx , utilization/formulary management and investigation resources to monitor potential fraud, waste and abuse supports members to achieve intended health outcomes
Clinical Update 6/22/2021 Diet and Dementia Which foods were linked to a lower risk of dementia in a recent study